SCHEMBL8701759

SCHEMBL8701759

C[SiH](C)OC[C@@]1(C(C)(C)C)CC(=O)CN1C(=O)OCc1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.42
RAB9A P51151 3/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
GAA P10253 1/20 0.42
MAPK1 P28482 1/20 0.42
HTR2C P28335 2/20 0.38
CTRB1 P17538 1/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
ALDH1A1 P00352 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
FKBP1A P62942 1/20 0.35
P2RX4 Q99571 2/20 0.35
DDB1 Q16531 1/20 0.35
CRBN Q96SW2 1/20 0.35
CYP2C19 P33261 1/20 0.35
PSEN1 P49768 1/20 0.35
PSEN2 P49810 1/20 0.35
APH1B Q8WW43 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8701753 1.00 NPC1 (0.42) NPC1RAB9ASMN1; SMN2GAAMAPK1
SCHEMBL7576836 0.88 HTR2C (0.37) NPC1RAB9ASMN1; SMN2GAAMAPK1
SCHEMBL3295186 0.80 HTR2C (0.40) NPC1RAB9ASMN1; SMN2HTR2CMEN1
SCHEMBL8699834 0.80 HTR2C (0.40) NPC1RAB9ASMN1; SMN2HTR2CMEN1
SCHEMBL18813753 0.74 NPC1 (0.49) NPC1RAB9ASMN1; SMN2GAAMAPK1
SCHEMBL18813754 0.74 NPC1 (0.49) NPC1RAB9ASMN1; SMN2GAAMAPK1
SCHEMBL2435139 0.72 SMN1; SMN2 (0.46) NPC1RAB9ASMN1; SMN2HTR2CMEN1
SCHEMBL2430964 0.70 SMN1; SMN2 (0.45) NPC1RAB9ASMN1; SMN2HTR2CMEN1
SCHEMBL13378597 0.69 NPC1 (0.41) NPC1RAB9ASMN1; SMN2GAAMAPK1
SCHEMBL19635980 0.68 NPC1 (0.50) NPC1RAB9ASMN1; SMN2GAAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5760029-A TREATING CANCER METASTASIS, DIABETIC RETINOPATHY, NEOVASCULAR GLAUCOMA, THROMBOSIS, RESTENOSIS, OSTEOPOROSIS, MACULAR DEGENERATION THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1998-06-02 US disclosed